Filing Details

Accession Number:
0001144204-14-067297
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-12 17:19:16
Reporting Period:
2014-11-12
Filing Date:
2014-11-12
Accepted Time:
2014-11-12 17:19:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
897075 Repros Therapeutics Inc. RPRX Biological Products, (No Disgnostic Substances) (2836) 760233274
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1476301 Katherine Anderson 2408 Timberloch Place, B-7
The Woodlands TX 77380
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-12 3,500 $9.41 11,875 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average of a range of purchase prices per share from $9.40 to $9.46. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company or any shareholder of the Company, upon request, full information regarding the number of shares purchased at each separate price.